Company Encyclopedia
View More
name
Semler Scientific
SMLR.US
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers.
1.391 T
SMLR.USMarket value -Rank by Market Cap -/-

Financial Score

22/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking72/172
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE17.74%A
    • Profit Margin130.80%A
    • Gross Margin91.51%A
  • Growth ScoreC
    • Revenue YoY-37.30%E
    • Net Profit YoY203.75%A
    • Total Assets YoY547.20%A
    • Net Assets YoY438.63%A
  • Cash ScoreD
    • Cash Flow Margin76.45%C
    • OCF YoY-37.30%E
  • Operating ScoreE
    • Turnover0.11E
  • Debt ScoreA
    • Gearing Ratio22.95%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Dir Chang Gifts 60,000 Of Semler Scientific Inc [SMLR]

    Chang William H Director of Semler Scientific Inc [SMLR] filed a Form 4 on December 17, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/15/25TransactionGiftShares60,000Price$0.00ValueN/AEnding Holdings: 824,264 - IndirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

    Reuters·
    US
    SMLR
    +4.79%
    Reuters·
    US
    SMLR
    +4.79%

    Semler Scientific Inc. (NASDAQ:SMLR) Receives Average Rating of "Moderate Buy" from Brokerages

    Semler Scientific Inc. (NASDAQ:SMLR) has received a consensus "Moderate Buy" rating from five brokerages. Analysts have set an average 12-month target price of $74.25. Recent reports show target price reductions by Benchmark and Maxim Group, while Weiss Ratings maintains a hold rating. Institutional investors have increased their positions in the company, which saw a stock surge of 130% in November. Semler Scientific reported strong quarterly earnings, with $1.07 EPS and a net margin of 130.80%.

    Market Beat·
    US
    SMLR
    +4.79%
    Market Beat·
    US
    SMLR
    +4.79%

    16:36 ET Semler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR

    Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating the proposed sale of Semler Scientific, Inc. to Strive, Inc. The investigation focuses on whether the transaction terms, offering 21.05 Class A common shares of Strive for each Semler share, adequately value Semler. Shareholders concerned about undervaluation or interested in their legal rights can contact KSF for more information.

    prnewswire·
    US
    SMLR
    +4.79%
    prnewswire·
    US
    SMLR
    +4.79%

    Strive Inc. Announces Acquisition of Semler Scientific

    Strive Inc. announced its acquisition of Semler Scientific, involving the issuance of Class A common stock to Semler's stockholders. The transaction requires approval from Semler's stockholders and may lead to increased costs, share dilution, and changes in customer or employee relationships. Details of directors' and officers' interests are filed with the SEC. The news was generated by AI and is for informational purposes only.

    Reuters·
    US
    ASST
    +8.15%
    US
    SMLR
    +4.79%
    Reuters·
    US
    ASST
    +8.15%
    US
    SMLR
    +4.79%

    Semler Scientific to Merge With Strive Asset Management in All-Stock Deal

    Semler Scientific plans to merge with Strive Asset Management in an all-stock deal, offering 21.05 Strive shares for each Semler share. The fixed exchange ratio won't adjust for market fluctuations. Since the merger announcement, Strive's stock price has dropped, affecting Semler's stock and making the deal less appealing to Semler shareholders. This was disclosed by Wohl & Fruchter LLP.

    Reuters·
    US
    SATA
    +0.80%
    US
    SMLR
    +4.79%
    US
    ASST
    +8.15%
    Reuters·
    US
    SATA
    +0.80%
    US
    SMLR
    +4.79%
    US
    ASST
    +8.15%
    © 2025 Longbridge｜Disclaimer